DarioHealth Corp.
Medical device company · New York, United States · Nasdaq: DRIO
DarioHealth Corp. is a medical device company headquartered in New York, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker DRIO. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2021.
DarioHealth at a glance
What does DarioHealth do?
Private fundraising reported to the SEC
19 Form D notices; the most recent reported $24 million sold (2021).
Frequently asked questions about DarioHealth
Where is DarioHealth headquartered?
DarioHealth Corp. is headquartered in New York, United States.
What does DarioHealth do?
DarioHealth Corp. is a medical device company. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.
Is DarioHealth a public company?
Yes. DarioHealth Corp. trades on Nasdaq under the ticker DRIO.
When was DarioHealth founded?
The earliest incorporation on record for DarioHealth Corp. is in 2011, according to public company registers.
Similar companies
- PAVmed Inc.New York City, New York, United States
- Lucid Diagnostics Inc.New York City, New York, United States
- Intelligent Bio Solutions Inc.New York City, New York, United States
- Fisher Wallace Laboratories, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
- Addinex Technologies, Inc.New York City, New York, United States
- Spark Neuro Inc.New York City, New York, United States
- Hyprevention Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences